Copyright
©The Author(s) 2021.
World J Gastroenterol. Oct 21, 2021; 27(39): 6673-6688
Published online Oct 21, 2021. doi: 10.3748/wjg.v27.i39.6673
Published online Oct 21, 2021. doi: 10.3748/wjg.v27.i39.6673
Studied parameters | CB, mU/L | LE, μg/L | TSA, mg% | LASA, mg% | ATA, U/mL |
CB, mU/L | -0.24 (187), P < 0.001 | ||||
LE, μg/L | 0.37 (140), P < 0.001 | 0.17 (141), P < 0.05 | |||
TSA, mg% | 0.37 (140), P < 0.001 | 0.19 (212), P < 0.01 | 0.33 (209), P < 0.001 | ||
LASA, mg% | 0.17 (141), P < 0.05 | 0.19 (212), P < 0.006 | -0.14 (210), P < 0.05 | ||
ATA, U/mL | -0.24 (187), P < 0.001 | 0.33 (209), P < 0.001 | -0.14 (210), P < 0.05 |
- Citation: Sebzda T, Gnus J, Dziadkowiec B, Latka M, Gburek J. Diagnostic usefulness of selected proteases and acute phase factors in patients with colorectal adenocarcinoma. World J Gastroenterol 2021; 27(39): 6673-6688
- URL: https://www.wjgnet.com/1007-9327/full/v27/i39/6673.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i39.6673